DrugPatentWatch Database Preview
Sun Pharm Inds Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for SUN PHARM INDS, and when can generic versions of SUN PHARM INDS drugs launch?
SUN PHARM INDS has two hundred and twelve approved drugs.
There are twelve US patents protecting SUN PHARM INDS drugs. There are four tentative approvals on SUN PHARM INDS drugs.
There are forty-two patent family members on SUN PHARM INDS drugs in twenty-three countries and one hundred and eighty supplementary protection certificates in fifteen countries.
Summary for Sun Pharm Inds
| International Patents: | 42 |
| US Patents: | 12 |
| Tradenames: | 156 |
| Ingredients: | 145 |
| NDAs: | 212 |
Drugs and US Patents for Sun Pharm Inds
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Inc | PRAMIPEXOLE DIHYDROCHLORIDE | pramipexole dihydrochloride | TABLET;ORAL | 091683-006 | Mar 27, 2013 | DISCN | No | No | Start Trial | Start Trial | |||||
| Sun Pharm Inds Ltd | OXYMORPHONE HYDROCHLORIDE | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 203506-005 | Apr 24, 2015 | DISCN | No | No | Start Trial | Start Trial | |||||
| Sun Pharm Inds Ltd | SIMVASTATIN | simvastatin | TABLET;ORAL | 076285-002 | Dec 20, 2006 | DISCN | No | No | Start Trial | Start Trial | |||||
| Sun Pharm Inds Ltd | TESTOSTERONE CYPIONATE | testosterone cypionate | INJECTABLE;INJECTION | 201720-001 | Jun 3, 2013 | AO | RX | No | No | Start Trial | Start Trial | ||||
| Sun Pharm Inds Ltd | RISPERIDONE | risperidone | TABLET, ORALLY DISINTEGRATING;ORAL | 077542-002 | Aug 6, 2010 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Sun Pharm Inds Ltd | MINOCYCLINE HYDROCHLORIDE | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 091118-007 | Dec 3, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sun Pharm Inds
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Inc | LAC-HYDRIN | ammonium lactate | LOTION;TOPICAL | 019155-001 | Apr 24, 1985 | 4,105,783 | Start Trial |
| Sun Pharm Inds Inc | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | 5,908,838 | Start Trial |
| Sun Pharm Inds Inc | BACTRIM | sulfamethoxazole; trimethoprim | INJECTABLE;INJECTION | 018374-001 | Approved Prior to Jan 1, 1982 | RE28636 | Start Trial |
| Sun Pharm Inds Inc | ULTRAVATE | halobetasol propionate | CREAM;TOPICAL | 019967-001 | Dec 27, 1990 | 4,619,921 | Start Trial |
| Sun Pharm Inds Inc | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-003 | Jul 11, 2012 | 5,908,838 | Start Trial |
| Sun Pharm Inds Inc | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-005 | Jul 11, 2012 | 5,908,838 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SUN PHARM INDS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-01-07 |
| ➤ Subscribe | Capsules | 35 mg | ➤ Subscribe | 2015-11-25 |
| ➤ Subscribe | Capsules | 30 mg and 40 mg | ➤ Subscribe | 2012-12-31 |
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-06-19 |
| ➤ Subscribe | Capsules | 25 mg | ➤ Subscribe | 2016-05-16 |
International Patents for Sun Pharm Inds Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2225600 | Start Trial |
| Japan | 2013213047 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2010017310 | Start Trial |
| Japan | 2008543936 | Start Trial |
| Australia | 8943801 | Start Trial |
| China | 1635881 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Inds Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0147850 | 99C0002 | Belgium | Start Trial | PRODUCT NAME: REPAGLINIDE; REGISTRATION NO/DATE: EU/1/98/076/001 19980817 |
| 0480717 | 98C0025 | Belgium | Start Trial | PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215 |
| 1506211 | CA 2014 00037 | Denmark | Start Trial | PRODUCT NAME: ET KOMBINATIONSPRODUKT AF DAPAGLIFLOZIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER DAPAGLIFLOZINPROPANDIOLMONOHYDRAT OG METFORMIN ELLER SALTE DERAF, HERUNDER METFORMINHYDROCHLORID; REG. NO/DATE: EU/1/13/900 20140116 |
| 0503785 | CA 2011 00026 | Denmark | Start Trial | PRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216 |
| 1915993 | 92315 | Luxembourg | Start Trial | PRODUCT NAME: COMBINAISON COMPRENANT ALISKIREN,OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE,ET AMLODIPINE,OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE |
| 1506211 | 122014000070 | Germany | Start Trial | PRODUCT NAME: KOMBINATION VON DAPAGLIFLOZIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON, UND METFORMIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON, GESCHUETZT DURCH DAS GRUNDPATENT EP 1 506 211; REGISTRATION NO/DATE: EU/1/13/900 20140116 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
